Epilepsy & Behavior. Ketogenic diet treatment in adults with refractory epilepsy
|
|
- Oswald Jacobs
- 6 years ago
- Views:
Transcription
1 Epilepsy & Behvior 19 (2010) Contents lists vilble t ScienceDirect Epilepsy & Behvior journl homepge: Ketogenic diet tretment in dults with refrctory epilepsy Pvel Klein,, Jromir Jnousek, Arkdy Brber, Rndi Weissberger b Mid-Atlntic Epilepsy nd Sleep Center, Bethesd, MD, USA b Individulized Nutrition Counseling, Bethesd, MD, USA rticle info bstrct Article history: Received 8 July 2010 Revised 6 September 2010 Accepted 8 September 2010 Keywords: Epilepsy Seizures Ketogenic diet Lipids The ketogenic diet (KD) is n effective tretment for refrctory epilepsy in children. It hs been little studied in dults. We evluted the efficcy of, sfety of, nd complince with djunctive KD tretment in dults with refrctory epilepsy in prospective open-lbel pilot study. Seizure frequency ws evluted for 4 bseline months, 4 months of djunctive KD tretment with 3:1 [ft]:[crbohydrte+protein] weight rtio nd 1600 kcl/dy, nd subsequent elective open-ended KD tretment. A 3:1 rtio ws used insted of the 4:1 rtio employed in children becuse of greter pltbility. Averge monthly seizure frequency nd seizurefree months t bseline were compred with KD months 1 4 (phse 1) nd ll KD tretment (phse 2). Diet complince ws evluted with dily urine ketone body nd monthly serum β-hydroxybutyrte levels. Twelve subjects were treted for up to 26 months. Three stopped tretment erly for psychosocil resons (n=2) or lck of efficcy. Seven of the 12 subjects were fully complint, 4 were prtilly complint, nd 1 ws noncomplint. seizure frequency declined by 38.4 nd 44.1% for phses 1 nd 2, respectively (P=0.04). Forty-two percent nd 50% of subjects hd N50% reduction during phses 1 nd 2, respectively. Four of 12 subjects (33%) hd N85% seizure reduction. Twenty percent of subject-months were seizure free t bseline versus 56% during both study phses (P=0.04). Adverse effects were mild: nuse, vomiting, dirrhe, constiption, nd weight loss Elsevier Inc. All rights reserved. 1. Introduction Seizures in pproximtely 35% of ptients with epilepsy fil to respond to ntiepileptic drug (AED) tretment [1 3]. The ketogenic diet (KD) is high-ft, low-protein, low-crbohydrte diet tht is n effective tretment for refrctory epilepsy in children [4,5]. The clssic diet consists of long-chin sturted triglycerides with 3:1 or 4:1 [ft]:[protein+crbohydrte] rtio by weight, with 90% of clories derived from ft. In open-lbel review or prospective studies of the KD in children, 7 15% of children with intrctble epilepsy become seizure free, 25 40% hve 90% seizure reduction, nd 55% hve N50% seizure reduction [6 11]. In study of 145 children rndomized to immedite KD versus KD delyed for 3 months, 38% of ptients in the KD group chieved N50% nd 7% N90% seizure frequency reduction versus 6 nd 0% in the control group [9]. These results compre fvorbly with the efficcy of new AEDs, which led to 1 7% seizure freedom rtes nd 90% seizure frequency reduction in fewer thn 10% ptients with intrctble epilepsy [12,13]. Tretment with the KD is reltively sfe. Potentil side effects in children include constiption or dirrhe, nuse, vomiting, nephrolithisis (3 7%), metbolic cidosis (2 5%), hyperuricemi (2 26%), Corresponding uthor. Mid-Atlntic Epilepsy nd Sleep Center, LLC 6410, Rockledge Drive, Suite 410, Bethesd, MD 20817, USA. Fx: E-mil ddress: kleinp@epilepsydc.com (P. Klein). hypoclcemi (2%), hypomgnesemi (5%), weight loss, hyperlipidemi, bruising, nd osteopeni [4,5,14 17]. Despite its success in children, the KD hs been little studied in dults. Only three studies in dults nd one in dolescents hve been published. In 1930 study 100 dults were treted with KD monotherpy for 1 yer, of whom 12% becme seizure free, 44% improved nd 44% remined unchnged [18]. More recently, there hve been only two smll reports. In one, 11 dults with refrctory epilepsy were treted for 8 months with djunctive 4:1 rtio KD. Three hd N90%, three hd 50 89%, nd one hd b50% seizure reduction; four stopped the diet premturely [19]. Adverse events (AEs) included constiption nd menstrul irregulrities. In nother study, nine dults with refrctory epilepsy were to be treted with the KD for 12 weeks. Only two subjects completed the study, both with N50% seizure frequency reduction; the rest dropped out becuse of side effects (dirrhe, hunger, elevted lipids) nd lck of efficcy [20]. Recently, two studies evluted the modified Atkins diet in dults. This diet hs 0.9: 1 [ft]: [crbohydrte+protein] weight rtio, with 65% of clories derived from ft. In one study of 30 dults, 33% subjects chieved N50% seizure reduction t 6 months; one subject becme seizure free [21], nd 33% stopped tretment before 3 months. In nother study with crbohydrte restriction of 20 g/dy, three of eight ptients continued with the diet for 6 months, with seizure reductions of N50%, N30%, nd b30% [22]. Given the pprent efficcy nd sfety of the KD in children nd the lck of effective tretment in dults with intrctble epilepsy, it is /$ see front mtter 2010 Elsevier Inc. All rights reserved. doi: /j.yebeh
2 576 P. Klein et l. / Epilepsy & Behvior 19 (2010) remrkble tht the KD hs not been evluted more brodly in dults. The min reson ppers to be n untested ssumption tht dults would not comply with the unpltble diet. The gol of the present study ws to obtin pilot dt on complince with nd efficcy nd sfety of djunctive KD tretment in dults with intrctble epilepsy. 2. Methods This prospective open-lbel study ws pproved by the institutionl review bord of Holy Cross Hospitl, Silver Spring, MD, USA. s signed institutionl review bord-pproved consent forms. The study ws performed in ccordnce with the ethicl stndrds of the 1964 Declrtion of Helsinki s Men nd women ged with refrctory primry generlized (PGE) or locliztion-relted (LRE) defined s filed tretment with three or more AEDs nd seizure frequency of 1 every 2 months were recruited. Epilepsy ws clssified using ILAE criteri [23]. Exclusion criteri were renl, liver, crdiovsculr or cerebrovsculr (therosclerotic), mitochondril, or ftty cid metbolism disese, history of renl clculi, hyperuricemi, hyperclcemi, porphyri, nd fmily history of hyperlipidemi Pretretment evlution s were evluted by tem consisting of n epileptologist, nutritionist, nd nurse. They met seprtely with ech tem member once or twice for 1-hour-long eduction visits. They were tught the cloric nd compositionl content of foods nd how to determine it. Bsl cloric intke ws clculted from retrospective recll dt nd prospective (7 dys) food records. A history of food llergies ws obtined. Smple recipes nd menus were creted tht incorported the subject's food preferences. s were given set of these recipes nd dily mel plns for five mels (three set mels nd two sncks) Initition of the ketogenic diet The ketogenic diet ws initited during 4- to 5-dy-long hospitliztion. s fsted for the first hours, followed by dily cloric increse to 33, 66, nd 100% of cloric trget. Urine ketone levels were checked t ech urintion using Ketostix (Byer AG, USA). s were tught to do the mesurements. Fst continued until urine ketones reched 40 mg/dl. Blood glucose ws checked for possible hypoglycemi every 2 hours during the first 48 hours, then every 6 hours. The protocol included glucose rescue pln if blood glucose fell to b50 mg/dl. The diet contined 3:1 [ft]: [protein +crbohydrte] weight rtio with 1600 kcl/dy cloric restriction, supplemented with vitmins, clcium, nd phosphorus to meet the requirements of stndrd U.S. Dietry Reference Intkes. Cloric restriction ws used bsed on trditionl usge of the KD Mintennce of ketogenic diet s were seen by n epileptologist nd nutritionist 1 week, 3 weeks, 5 weeks, nd 2 months fter dischrge, then monthly by the epileptologist nd every 3 months by the nutritionist. If seizures did not improve fter 2 months, the KD rtio ws incresed to 4: Evlutions Seizure frequency ws evluted prospectively for 4 months t bseline nd 4 26 months fter initition of the KD with dily seizure diry. AEDs were held stble during the bseline observtion nd KD period. At ech visit, seizure frequency, tretment complince, nd AEs were evluted nd physicl exmintion ws performed. Body mss index (BMI) ws clculted. Ptients checked urine for ketones with Ketostix one to three times dily nd documented results in combined ketone/seizure diry which ws reviewed t ech visit. Urine Ketostix mesures urine cetocette with colorcoded scle with ketone body (KB) level brckets of 15, 40, 80, nd 160 mg/dl. Diet complince ws ssessed by mesuring dily urine KBs nd monthly serum β-hydroxybutyrte (BOHB) levels. Urine KB complince ws scored on scle of 0 3, where 0 =no complince (KB detectble on 75% of dys); 1=mild (KB=N15 b40 on 75% of dys); 2=moderte (KB 40 on 75% of dys; 3=complete (KB 40 on 95% of dys). Undocumented dys were counted s 0. Serum BOHB complince ws scored monthly s 1 when BOHB ws elevted bove norml (0 3 mmol/l), 0 when it ws not, nd clculted s the percentge of study months with complince. Urine KB nd serum BOHB complinces were converted to frctions (e.g., urine KB 1=0.33, 2=0.66, 3=1.00), combined, nd verged to yield n overll complince score: b10%=0, b50%=1, b90%=2, 100% =3. Qulity of life ws evluted t ech visit with the Ptient-Weighted Qulity of Life in Epilepsy inventory (QOLIE-31-P). Alertness ws evluted with the Epworth Sleepiness Scle (ESS). Lbortory evlutions included CBC, CMP, BOHB,.m. fsting (10-hour) lipid levels (cholesterol, triglycerides [TGs], high, low nd very low density lipoprotein (HDL, LDL nd VLDL), glucose nd insulin levels, glycosylted hemoglobin (HBA 1c ), leptin levels (becuse of the ssocition of KD with weight loss nd of serum leptin levels with weight loss), serum trough AED levels, nd urine clcium nd cretinine level (for risk of nephrolithisis). These were done 1 month before KD initition, on dy 1 of the fst, nd then monthly. s treted for N3 months who stopped the diet hd lipid levels checked monthly for 3 months fter KD discontinution. The primry efficcy im ws comprison of verge monthly seizure frequency during the 4-month bseline with tht during the 4 months of KD tretment. s who elected to continue KD tretment beyond 4 months were evluted monthly for tretment months 5 12, then every 2 months. The secondry efficcy im ws comprison of verge monthly seizures during bseline with those for the whole tretment durtion. Other outcome mesures included proportion of seizure-free months, rte of KD discontinution, AEs, weight, BMI, QOLIE-31-P scores, nd ESS scores. Dt were nlyzed using Wilcoxon's test for nonprmetric nd Student's t test for normlly distributed continuous vribles (ll two-tiled). Significnce ws set t Pb Results 3.1. Demogrphics/disese chrcteristics Demogrphics, disese chrcteristics, nd bseline tretment re summrized in Tble 1. Twelve subjects were enrolled (eight women, four men, ge rnge 24 65). An dditionl 23 eligible ptients were screened nd declined prticiption becuse of reluctnce to give up their regulr diet (n=17), the complexity of the KD (n=5), nd cost. The screened to enrolled rtio ws 35/12 (2.92) disposition Tretment lsted 4 dys to 26 months (Tble 2). Three subjects discontinued tretment during the first 4 months for psychosocil resons (n=2, t 4 dys nd 1.5 months) nd lck of efficcy (n=1 t 2.5 months). Nine of twelve subjects elected to continue tretment pst the initil 4-month study period, including six subjects treted for
3 P. Klein et l. / Epilepsy & Behvior 19 (2010) Tble 1 Ptient demogrphics nd epilepsy/seizure nd clinicl chrcteristics. Sex Age Epilepsy type Age t epilepsy onset Seizure type of pst AEDs Current AEDs (mg/dy) Comorbidity 1 F 24 PGE 7 GTC, Abs, Myo 8 TPM 1000 Obesity, depression, T 4 VNS (inctive) 2 F 40 PGE 3 GTC, Abs, Myo 7 TPM 350 Obesity, OSA, hypertension, peptic ulcertive disese, T 4 3 M 34 PGE 23 GTC 3 LEV 3000, TPM 50 Obesity, OSA 4 F 46 PGE/JME 10 GTC, Abs, Myo 8 LEV 5000, LTG 600 Obesity, OSA, depression 5 F 65 PGE 27 GTC, Myo 2 LEV 2000 Obesity, OSA, depression, non-insulin-dependent dibetes mellitus 6 F 44 LRE 10 CPS 7 LEV 3000, TPM 400, LTG 300, CBZ 600 Obesity, OSA, perimenopuse 7 F 53 LRE 2 CPS 8 TPM 200, OXC 2100 Obesity, perimenopuse 8 F 33 LRE 13 CPS 8 OXC 1800, LTG 425, TGB 10 None 9 M 37 LRE 31 SPS/CPS 6 LEV 4500, PGB 800, VPA 2000, CBZ 1200 Neurocytom, obesity, 10 F 40 LRE 12 CPS 5 LEV 3000, CBZ 1400, VNS Obesity 11 M 35 LRE 25 SPS/CPS 6 LEV 3000, OXC 600, PGB 800 Anxiety 12 M 24 LRE 10 CPS/GTC 2 OXC 600 Autism, pervsive developmentl disorder PGE, primry generlized epilepsy; LRE, locliztion-relted epilepsy; Ab, bsence seizures; Myo, myoclonic seizures; GTC, generlized tonic clonic; CPS, complex prtil seizures; SPS, simple prtil seizures; CBZ, crbmzepine; LEV, levetircetm; LTG, lmotrigine; OXC, oxcrbzepine; PGB, pregblin; TGB, tigbine; TPM, topirmte; VPA, vlprote; T 4, hypothyroidism; OSA, obstructive sleep pne; VNS, vgus nerve stimultion. N8 months nd four subjects treted for 20 months. Four subjects stopped the KD fter 7, 8, 24, nd 25 months becuse of n unplnned pregnncy (n=1) nd desire for regulr food (n=3). Five subjects re still in tretment (durtion: 6 20 months) Tretment complince Seven of twelve subjects were fully complint (three on the scle of 0 3), including the subject who stopped the KD for lck of efficcy. Two of twelve subjects were modertely (2) nd mildly (1) complint. One subject ws noncomplint (0) nd stopped tretment fter 4 dys (Tble 2) Seizure control Tbles 2 nd 3 summrize dt on generlized tonic clonic seizures (GTC) in subjects with PGE nd complex prtil seizures (CPS) in subjects with LRE. Becuse of the lesser relibility of bsence, myoclonic, nd simple prtil seizure counts, dt nlysis below is confined to GTC seizures/cps. Dt on bsence, myoclonic, nd simple prtil motor seizures re summrized in Supplementl Tble 2 (see Appendix A). Ten of twelve subjects improved, one did not chnge, nd one worsened. Averge monthly seizure frequency for the 11 subjects treted for N1 week declined by 38.4% for KD months 1 4 (P=0.05) nd by 44.1% for the whole tretment durtion (P=0.04). Four of twelve (33%) subjects hd N75% seizure reduction, including one subject who stopped tretment fter 1.5 months; excluding her, 3 of 12 (25%) subjects did. Five of twelve (42%) subjects hd N50% seizure reduction during KD months 1 4, nd 6 of 12 (50%) during the whole tretment; n dditionl 4 of 12 subjects experienced 20 50% seizure reductions during both study phses. During bseline, 20% of subject-months were seizure-free compred with 56% during both study phses (P=0.04). Response to tretment ws fst. In ll subjects with N75% seizure reduction, the full effect occurred during the first month of tretment. In four subjects with dily bsence/myoclonic seizures, response reched its full extent within 4 dys of KD initition. Three subjects with N75% seizure reduction (two with PGE, one with LRE) stopped the diet, fter 1.5, 8, nd 18 months. In ll three, seizures returned to pretretment frequency fter 1 7 months. One successfully restrted the KD. Two subjects with no improvement on the 3:1 diet (both fully complint) incresed the [ft]:[crbohydrte/protein] rtio to 4:1 Tble 2 Monthly frequency of only generlized tonic clonic nd complex prtil seizures for 4-month bseline, KD tretment months 1 4, nd whole tretment durtion. Tretment durtion (months) Seizure frequency/month % Chnge AED chnge on KD Complince Bseline KD months 1 4 Whole tretment KD months 1 4 Whole tretment dc 2/ dc 1/4, dose 2/ b 0.13 n n n n n n 0 b c 2.07 (2.36) 0.99 c (1.56) Complince grding: 0=none; 1=mild, 2=moderte, 3=complete. dropped out fter 4 dys nd is not included in dt nlysis. P=0.05. d P = d (1.58)
4 578 P. Klein et l. / Epilepsy & Behvior 19 (2010) Tble 3 Seizure-free months for 4-month bseline, KD months 1 4, nd whole tretment durtion. fter 2 months. One did not improve nd stopped the diet. Another subject improved nd hs continued with the diet (17 months to dte). Antiepileptic drugs were held constnt in 9 of 11 subjects treted for N1 week. Two subjects reduced AEDs: one subject decresed from four to three AEDs t 6 months, nd nother subject self-discontinued two of two AEDs fter 1 month nd hs continued on the KD lone (20 months to dte) Sfety nd tolerbility No subjects discontinued tretment becuse of AEs. AEs were mild nd included trnsient nuse (n=1), dirrhe (n=2), nd constiption (n=1) during KD initition, nd nuse (n=2), isolted vomiting (n=2), bdominl crmps (n=1), nd mild intermittent constiption (n=4) during KD mintennce. Three subjects (25%) hd mild intermittent hunger, rted 2 3 on scle of Weight Tretment durtion (months) Cloric intke ws reduced from bseline verge of 2412 kcl/ person/dy (rnge= , medin=2400) to 1600 kcl/dy. All 11 subjects treted for N1 week lost weight (Tble 4). Their men weight declined by 38.7 lb from lb t bseline to (rnge=4 80 lb, Pb0.001). BMI ws reduced by 18.3%, from 33.8 to 27.5 kg/m 2 (rnge = %, P b0.001). Eight of nine overweight or obese subjects (BMI= nd 30 kg/m 2, respectively [24]) hd 10% BMI reduction, seven of nine 15%, nd four of nine 20%. The only obese subject who lost b10% of BMI stopped tretment fter 1.5 months. One overweight nd two obese subjects normlized their BMI, nd third obese ptient nernormlized it (BMI=25.8). The weight loss ws ssocited with reduction of men serum leptin levels in 10 of 10 subjects in whom leptin ws mesured, from men bseline 26.6 ng/ml to 12.9 ng/dl (P=0.001) Lipids, glucose, nd other lbs Seizure-free months Bseline KD months Whole 1 4 tretment / / / / / / / / /2.5 0/ / / / c 0.13 N/A N/A N 0 Totl 9/ / /140 % seizure free d 56.1 d Complince b N/A, not pplicble. Tretment months 1 4 re 4 months except for subjects who discontinued tretment erly, for whom number of seizure-free months/number of months on tretment is given. b Complince grding: 0=none; 1=mild, 2=moderte, 3=complete. c dropped out fter 4 dys nd is not included in dt nlysis. d P =0.04. serum cholesterol levels incresed from to mg/dl (P=0.04). TG, HDL, LDL, nd VLDL levels did not chnge significntly Tble 4 Effect of KD on BMI, weight, nd blood leptin levels. (Tble 5). Five of six subjects who stopped the KD fter N1 month hd n increse in serum lipids on the KD. Lipid levels returned to bseline within 3 months of stopping KD, including 3 subjects treted with sttins, in whom sttins were stopped fter the KD ws discontinued. fsting glucose levels were higher t bseline compred with KD mintennce (87.7 mg/dl vs 78.7 mg/dl, P=0.04). glucose levels declined during KD initition, from mg/dl on dys 1 2 to mg/dl on dys 3 5 (p=0.008). There ws no significnt chnge in men pek plsm uric cid levels: 5.6 mg/dl t bseline versus 6.06 mg/dl on the KD Qulity of life QOLIE-31-P globl scores rose nonsignificntly from 5.25 t bseline to 7. ESS scores did not chnge significntly (7.9/24 t bseline vs 7.4/24 t lst KD visit). 4. Discussion BMI (kg/m 2 ) Weight (lb) Leptin (ng/ml) Bseline KD % Chnge Bseline KD Bseline KD n n (6.83) b (5.87) (42.37) b (32.9) (17.23) 12.9 c (17.43) Lowest BMI/weight/leptin level during tretment. BMI nd leptin levels re rounded to the nerest deciml point, weight to the nerest pound. b P b c pb This open-lbel study of djunctive KD tretment in dults with refrctory epilepsy resulted in overll seizure improvement, including N75% seizure frequency reduction in 25% of subjects treted for N4 months. The tretment ws well tolerted nd hd good complince. The study shows tht KD tretment in dults is fesible. The study differs from the two previous completed studies of KD tretment in dults with epilepsy in tht the tretment durtion ws long nd there ws follow-up of subjects fter tretment discontinution to evlute possible disese-modifying properties of the KD in dults. It is the first study of KD tretment, to our knowledge, to incorporte quntittive mesurement of complince. Limittions of the study include its smll size, uncontrolled selection of subjects, nd the open-lbel, nonrndomized design. Despite its success in the tretment of children with refrctory epilepsy, the KD hs been little evluted in dults with refrctory epilepsy, with only 20 subjects in two studies reported since 1930, nd only 13 of these subjects treted for 12 weeks or longer [19,20]. The ssumption hs been tht dults my not comply with the unpltble nd complicted diet. The present study suggests tht this my not be true. The modified Atkins diet hs been tried in dults insted of the KD in the belief tht complince would be better [21,22]. The Atkins diet shres with the KD crbohydrte restriction. However, it differs significntly from the clssic ketogenic diet: only 60 65% of clories re ft-derived, nd protein content is higher. It hs been less studied in children thn the KD. We therefore chose to study the "clssic" KD.
5 P. Klein et l. / Epilepsy & Behvior 19 (2010) Tble 5 Fsting serum lipid levels t bseline nd on KD, mesured t the end of KD tretment (the lst vlue for subjects still on tretment) or before initition of tretment with lipidlowering gents (sttins, n=3). Bseline KD Sttin Chol TG HDL VLDL LDL Chol TG HDL VLDL LDL trement Yes Yes Yes n P = (38.38) (81.47) 59.6 (20.4) 22.1 (16.3) (40.52) (107.3) 60.4 (15.82) 25.5 (16,16) (81.27) We used the 3:1 rtio becuse it my be more pltble thn the 4:1 rtio often used in children. Seventy-five percent of our subjects completed the plnned 4 months of the study nd elected to continue KD tretment beyond the initil 4 months. This rte of subject retention is similr to retention rtes in investigtionl AED phse 3 studies nd their open-lbel extensions [12]. However, two thirds of potentilly eligible subjects declined to prticipte becuse of the restrictive nd complex nture of the diet. This mde recruitment into the study chllenging, nd could be limiting fctor in lrger KD studies. The efficcy dt in this study re similr to those from peditric studies, nd suggest tht the KD my be very effective in proportion of dults. Twenty-five percent of our subjects treted long term hd N75% seizure frequency reduction nd 42% hd N50% reduction. This is in line with recent rndomized peditric study in which 38% of subjects hd N50% nd 7% hd N90% seizure frequency reduction [9], nd is similr to the only other completed modern dult KD study in which 3 of 11 subjects hd N90% seizure reduction nd 55% hd 50% seizure decrese [20]. Tht study diet used 4:1 [ft]: [crbohydrte/protein] rtio. Our dt suggest tht the 3:1 rtio my be similrly effective. In peditric studies, the ntiepileptic effect my persist fter KD discontinution [11]. Adult studies hve not previously evluted the effect of KD on epilepsy fter tretment discontinution. In our study, seizure improvement did not outlst KD tretment. This indictes possible difference between dult nd peditric responses to the KD. Tretment noncomplince is common trigger of seizures [25]. It cn be expected to be worse with the KD becuse of the diet's restrictive nd complicted nture, mking monitoring importnt. We used combined quntittive self-reported dily urine nd serum ketone body level mesurements, llowing comprison of subjectbsed nd subject-independent complince evlution tht could be used in future studies. Monitoring diet complince with urinry ketosis hs limittions becuse urinry ketosis my be reduced by fctors other thn complince, such s use of crbohydrte-contining medictions, liver dysfunction, or overhydrtion; however, t present, it is the only method vilble short of direct food intke observnce. Appendix A. Supplementl dt Supplementry dt ssocited with this rticle cn be found, in the online version, t doi: /j.yebeh References [1] Kwn P, Brodie MJ. Erly identifiction of refrctory epilepsy. N Engl J Med 2000;342: [2] Mttson RH, Crmer JA, Collins JF, et l. Comprison of crbmzepine, phenobrbitl, phenytoin, nd primidone in prtil nd secondrily generlized tonic clonic seizures. N Engl J Med 1985;313: [3] Cscino GD. When drugs nd surgery don't work. Epilepsi 2008;49(Suppl 9): [4] Hrtmn AL, Vining EP. Clinicl spects of the ketogenic diet. Epilepsi 2007;48: [5] Kossoff EH, Zupec-Kni BA, Amrk PE, et l. Optiml clinicl mngement of children receiving the ketogenic diet: recommendtions of the Interntionl Ketogenic Diet Study Group. Epilepsi 2009;50: [6] Freemn JM, Vining EPG, Pills DJ, Csey JC, Kelly LM. The efficcy of the ketogenic diet 1998: prospective evlution of intervention in 150 children. Peditrics 1998;102: [7] Lefevre F, Aronson N. Ketogenic diet for the tretment of refrctory epilepsy in children: systemtic review of efficcy. Peditrics 2000;105(E46):1 7. [8] Keene DL. A systemtic review of the use of the ketogenic diet in childhood epilepsy. Peditr Neurol 2006;35:1 5. [9] Nel EG, Chffe HM, Edwrds N, et l. The ketogenic diet for the tretment of childhood epilepsy: rndomised controlled tril. Lncet Neurol 2008;7: [10] Hrtmn AL, Gsior M, Vining EPG, Rogwski MA. The neurophrmcology of the ketogenic diet. Peditr Neurol 2007;36: [11] Hemingwy C, Freemn JM, Pills DJ, Pyzik PL. The ketogenic diet: 3- to 6-yer follow-up of 150 children enrolled prospectively. Peditrics 2001;108: [12] Gzzol DM, Blcer LJ, French JA. Seizure-free outcome in rndomized dd-on trils of the new ntiepileptic drugs. Epilepsi 2007;48: [13] Kwn P, Brodie MJ. Emerging drugs for epilepsy. Expert Opin Emerg Drugs 2007;12: [14] Vining EP. Long-term helth consequences of epilepsy diet tretments. Epilepsi 2008;49(Suppl 8):27 9. [15] Kng HC, Chung d E, Kim DW, Kim HD. Erly- nd lte-onset complictions of the ketogenic diet for intrctble epilepsy. Epilepsi 2004;45: [16] Furth SL, Csey JC, Pyzik PL, et l. Risk fctors for urolithisis in children on the ketogenic diet. Peditr Nephrol 2000;15: [17] Kwiterovich Jr PO, Vining EP, Pyzik P, Skolsky R, Freemn JM. Effect of high-ft ketogenic diet on plsm levels of lipids, lipoproteins, nd polipoproteins in children. JAMA 2003;290: [18] Brbork C. Epilepsy in dults: results of tretment by ketogenic diet in one hundred cses. Arch Neurol 1930;6: [19] SirvenJ, Whedon B, CplnD, LiporceJ, GlosserD, O'Dwyer J, etl. Theketogenic diet for intrctble epilepsy in dults: preliminry results. Epilepsi 1999;40: [20] Mosek A, Ntour H, Neufeld MY, Shiff Y, Vismn N. Ketogenic diet tretment in dults with refrctory epilepsy: prospective pilot study. Seizure 2009;18:30 3. [21] Kossoff EH, Rowley H, Sinh SR, Vining EPG. A prospective study of the modified Atkins diet for intrctble epilepsy in dults. Epilepsi 2008;49: [22] Crrette E, Vonck K, de Herdt V, et l. A pilot tril with modified Atkins' diet in dult ptients with refrctory epilepsy. Clin Neurol Neurosurg 2008;110: [23] Commission on Clssifiction nd Terminology of the Interntionl Legue Aginst Epilepsy. Proposl for revised clssifiction of epilepsies nd epileptic syndromes. Epilepsi 1989;30: [24] Aronne LJ. Clssifiction of obesity nd ssessment of obesity-relted helth risks. Obes Res 2002;10:105S 15S. [25] Mttson RH. Emotionl effects on seizure occurrence. Adv Neurol 1991;55:
Clinical Study Report Synopsis Drug Substance Naloxegol Study Code D3820C00018 Edition Number 1 Date 01 February 2013 EudraCT Number
EudrCT Number 2012-001531-31 A Phse I, Rndomised, Open-lbel, 3-wy Cross-over Study in Helthy Volunteers to Demonstrte the Bioequivlence of the Nloxegol 25 mg Commercil nd Phse III Formultions nd to Assess
More informationCheckMate 153: Randomized Results of Continuous vs 1-Year Fixed-Duration Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer
CheckMte 53: Rndomized Results of Continuous vs -Yer Fixed-Durtion Nivolumb in Ptients With Advnced Non-Smll Cell Lung Cncer Abstrct 297O Spigel DR, McCleod M, Hussein MA, Wterhouse DM, Einhorn L, Horn
More informationThe RUTHERFORD-2 trial in heterozygous FH: Results and implications
The RUTHERFORD-2 tril in heterozygous FH: Results nd implictions Slide deck kindly supplied s n eductionl resource by Professor Derick Rl MD PhD Crbohydrte & Lipid Metbolism Reserch Unit University of
More informationThe Effects of Small Sized Rice Bowl on Carbohydrate Intake and Dietary Patterns in Women with Type 2 Diabetes
Originl Article doi: 10.4093/kdj.2010.34.3.166 pissn 1976-9180 eissn 2093-2650 The Effects of Smll Sized Rice Bowl on Crbohydrte Intke nd Dietry Ptterns in Women with Type 2 Dibetes Hee-Jung Ahn 1, *,
More informationEfficacy of Pembrolizumab in Patients With Advanced Melanoma With Stable Brain Metastases at Baseline: A Pooled Retrospective Analysis
Efficcy of Pembrolizumb in Ptients With Advnced Melnom With Stble Brin Metstses t Bseline: A Pooled Retrospective Anlysis Abstrct 1248PD Hmid O, Ribs A, Dud A, Butler MO, Crlino MS, Hwu WJ, Long GV, Ancell
More informationSafety and Tolerability of Subcutaneous Sarilumab and Intravenous Tocilizumab in Patients With RA
Sfety nd Tolerbility of Subcutneous Srilumb nd Intrvenous Tocilizumb in Ptients With RA Pul Emery, 1 Jun Rondon, 2 Anju Grg, 3 Hubert vn Hoogstrten, 3 Neil M.H. Grhm, 4 Ming Liu, 4 Nncy Liu, 3 Jnie Prrino,
More informationSYNOPSIS Final Abbreviated Clinical Study Report for Study CA ABBREVIATED REPORT
Finl Arevited Clinicl Study Report Nme of Sponsor/Compny: Bristol-Myers Squi Ipilimum Individul Study Tle Referring to the Dossier (For Ntionl Authority Use Only) Nme of Finished Product: Yervoy Nme of
More informationFat intake in patients newly diagnosed with type 2 diabetes: a 4-year follow-up study in general practice
Originl ppers Ft intke in ptients newly dignosed with type 2 dibetes: 4-yer follow-up study in generl prctice Floris A vn de Lr, Eloy H vn de Lisdonk, Peter L B J Lucssen, J M H Tigchelr, Sski Meyboom,
More informationEffect on Glycemic, Blood Pressure, and Lipid Control according to Education Types
Originl Article http://dx.doi.org/10.4093/dmj.2011.35.6.580 pissn 2233-6079 eissn 2233-6087 D I A B E T E S & M E T A B O L I S M J O U R N A L Effect on Glycemic, Blood Pressure, nd Lipid Control ccording
More informationOriginal Article INTRODUCTION. Korean Diabetes J 2010;34: doi: /kdj pissn eissn
Originl Article doi: 1.493/kdj.21.34.6.34 pissn 1976-918 eissn 293-265 The Smll Rice Bowl-Bsed Mel Pln ws Effective t Reducing Dietry Energy Intke, Body Weight, nd Blood Glucose Levels in Koren Women with
More informationEVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1
Swine Dy 2001 Contents EVALUATION OF DIFFERENT COPPER SOURCES AS A GROWTH PROMOTER IN SWINE FINISHING DIETS 1 C. W. Hstd, S. S. Dritz 2, J. L. Nelssen, M. D. Tokch, nd R. D. Goodbnd Summry Two trils were
More informationEFFECTS OF INGREDIENT AND WHOLE DIET IRRADIATION ON NURSERY PIG PERFORMANCE
Swine Dy 21 EFFECTS OF INGREDIENT AND WHOLE DIET IRRADIATION ON NURSERY PIG PERFORMANCE J. M. DeRouchey, M. D. Tokch, J. L. Nelssen, R. D. Goodbnd, S. S. Dritz 1, J. C. Woodworth, M. J. Webster, B. W.
More informationSupplementary Online Content
Supplementry Online Content Zulmn DM, Pl Chee C, Ezeji-Okoye SC, et l. Effect of n intensive outptient progrm to ugment primry cre for high-need Veterns Affirs ptients: rndomized clinicl tril. JAMA Intern
More informationMetabolic Syndrome and Health-related Quality of Life in Obese Individuals Seeking Weight Reduction
Metbolic Syndrome nd Helth-relted Qulity of Life in Obese Individuls Seeking Weight Reduction Adm Gilden Tsi 1, Thoms A. Wdden 1, Dvid B. Srwer 1, Robert I. Berkowitz 1, Leslie G. Womble 1, Louise A. Hesson
More informationA review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital
MEDICAL ONCOLOGY A review of the ptterns of docetxel use for hormone-resistnt prostte cncer t the Princess Mrgret Hospitl S.N. Chin MD,* L. Wng MSc, M. Moore MD,* nd S.S. Sridhr MD MSc* ABSTRACT Bckground
More informationAssessment of Depression in Multiple Sclerosis. Validity of Including Somatic Items on the Beck Depression Inventory II
Assessment of Depression in Multiple Sclerosis Vlidity of Including Somtic Items on the Beck Depression Inventory II Peggy Crwford, PhD; Noh J. Webster, MA Signs nd symptoms of multiple sclerosis (MS)
More informationImpact of Pharmacist Intervention on Diabetes Patients in an Ambulatory Setting
Impct of Phrmcist Intervention on Dibetes Ptients in n Ambultory Setting Julie Stding, PhrmD, CDE, Jmie Herrmnn, PhrmD, Ryn Wlters, MS, Chris Destche, PhrmD, nd Aln Chock, PhrmD Dibetes is the seventh-leding
More informationTarget: 10 mg/day within several days Schizophrenia in adolescents (2.1)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include ll the informtion needed to use ZYPREXA sfely nd effectively. See full prescribing informtion for ZYPREXA. ZYPREXA (olnzpine) Tblet
More informationStart ORKAMBI today. INDICATIONS AND USAGE IMPORTANT SAFETY INFORMATION. Sydney Age 4
F O R H E A L T H C A R E P R O F E S S I O N A L S For ptients ge 2 yers nd older who re homozygous for the F508del muttion 1,2 Modify the course. Strt tody. Sydney Age 4 F508del/F508del INDICATIONS AND
More informationIn the treatment of cardiovascular disease (CVD), national
n report n Beyond LDL Cholesterol: The Role of Elevted Triglycerides nd Low HDL Cholesterol in Residul CVD Risk Remining After Sttin Therpy Peter Algon Jr, MD, FACC In the tretment of crdiovsculr disese
More informationXII. HIV/AIDS. Knowledge about HIV Transmission and Misconceptions about HIV
XII. HIV/AIDS Knowledge bout HIV Trnsmission nd Misconceptions bout HIV One of the most importnt prerequisites for reducing the rte of HIV infection is ccurte knowledge of how HIV is trnsmitted nd strtegies
More informationAnalysis of alternatives for insulinizing patients to achieve glycemic control and avoid accompanying risks of hypoglycemia
284 Anlysis of lterntives for izing ptients to chieve glycemic control nd void ccompnying risks of hypoglycemi JIALIN GAO 1,2*, QIANYIN XIONG 1,2*, JUN MIAO 1*, YAO ZHANG 2,3, LIBING XIA 1, MEIQIN LU 1,
More informationEfficacy of Sonidegib in Patients With Metastatic BCC (mbcc)
AAD 216 eposter 3368 Efficcy of Sonidegib in Ptients With Metsttic BCC (mbcc) Colin Morton, 1 Michel Migden, 2 Tingting Yi, 3 Mnish Mone, 3 Dlil Sellmi, 3 Reinhrd Dummer 4 1 Stirling Community Hospitl,
More informationCommunity. Profile Big Horn County. Public Health and Safety Division
Community Helth Profile 2015 Big Horn County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationOriginal Article. T Akter 1, N Islam 2, MA Hoque 3, S Khanam 4, HA khan 5, BK Saha 6. Abstract:
Fridpur Med. Coll. J. 214;9(2):61-67 Originl Article Nebuliztion by Isotonic Mgnesium Sulphte Solution with Provide Erly nd Better Response s Compred to Conventionl Approch ( Plus Norml Sline) in Acute
More informationSmall Rice Bowl-Based Meal Plan for Energy and Marcronutrient Intake in Korean Men with Type 2 Diabetes: A Pilot Study
Originl Article doi: 1.493/dmj.11.35.3.73 pissn 33-679 eissn 33-687 D I A B E T E S & M E T A B O L I S M J O U R N A L Smll Rice Bowl-Bsed Mel Pln for Energy nd Mrcronutrient Intke in Koren Men with Type
More informationThe Acute Time Course of Concurrent Activation Potentiation
Mrquette University e-publictions@mrquette Exercise Science Fculty Reserch nd Publictions Exercise Science, Deprtment of 1-1-2010 The Acute Time Course of Concurrent Activtion Potentition Luke Grceu Mrquette
More informationOptimisation of diets for Atlantic cod (Gadus morhua) broodstock: effect of arachidonic acid on egg & larval quality
Optimistion of diets for Atlntic cod (Gdus morhu) roodstock: effect of rchidonic cid on egg & lrvl qulity Dr Gordon Bell, Ms. An Blnco, Dr Bill Roy, Dr Derek Roertson, Dr Jim Henderson nd Mr Richrd Prickett,
More informationPresented at the 75 th Annual Meeting of the American Academy of Dermatology, Orlando, FL, March 3-7, 2017 METHODS INTRODUCTION OBJECTIVE
Seven-Yer Interim Results from the ESPRIT 10-Yer Postmrketing Surveillnce Registry of Adlimumb for Moderte to Severe Psorisis Frncisco Kerdel, 1 Aln Menter, 2 Jshin J. Wu, 3 Mreike Bereswill, 4 Dilek Arikn,
More informationAddendum to the Evidence Review Group Report on Aripiprazole for the treatment of schizophrenia in adolescents (aged years)
Addendum to the Evidence Review Group Report on Aripiprzole for the tretment of schizophreni in dolescents (ged 15-17 yers) Produced by Authors Correspondence to Southmpton Helth Technology Assessments
More informationIntroduction. These patients benefit less from conventional chemotherapy than patients identified as MMR proficient or microsatellite stable 3-5
Nivolumb + Ipilimumb Combintion in Ptients With DNA Mismtch Repir-Deficient/Microstellite Instbility-High Metsttic Colorectl Cncer: First Report of the Full Cohort From CheckMte-142 Abstrct 553 André T,
More informationDiabetes affects 29 million Americans, imposing a substantial
CLINICAL Comprtive Effectiveness nd Costs of Insulin Pump Therpy for Dibetes Ronld T. Ackermnn, MD, MPH; Amish Wlli, MD, MS; Rymond Kng, MA; Andrew Cooper, MPH; Theodore A. Prospect, FSA, MAAA; Lewis G.
More informationA Comparative Study of Eating Habits and Food Intake in Women with Gestational Diabetes according to Early Postpartum Glucose Tolerance Status
Originl Article http://dx.doi.org/10.4093/dmj.2011.35.4.354 pissn 2233-6079 eissn 2233-6087 D I A B E T E S & M E T A B O L I S M J O U R N A L A Comprtive Study of Eting Hbits nd Food Intke in Women with
More informationCommunity. Profile Powell County. Public Health and Safety Division
Community Helth Profile 2015 Powell County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationCommunity. Profile Yellowstone County. Public Health and Safety Division
Community Helth Profile 2015 Yellowstone County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Anaconda- Deer Lodge County. Public Health and Safety Division
Community Helth Profile 2015 Ancond- Deer Lodge County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12
More informationAbstract. Background. Aim. Patients and Methods. Patients. Study Design
Impct of the Use of Drugs nd Substitution Tretments on the Antivirl Tretment of Chronic Heptitis C: Anlysis of Complince, Virologicl Response nd Qulity of Life (CHEOBS). Melin, 1 J.-. Lng, D. Ouzn, 3 M.
More informationCommunity. Profile Lewis & Clark County. Public Health and Safety Division
Community Helth Profile 2015 Lewis & Clrk County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl
More informationCommunity. Profile Missoula County. Public Health and Safety Division
Community Helth Profile 2015 Missoul County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationOriginal Article. Diabetes Metab J 2011;35:26-33 doi: /dmj pissn eissn
Originl Article Dibetes Metb J 211;35:26-33 doi: 1.493/dmj.211.35.1.26 pissn 2233-679 eissn 2233-687 D I A B E T E S & M E T A B O L I S M J O U R N A L Comprison of the Efficcy of Glimepiride, Metformin,
More informationobesità nel bambino: epidemiologia e prevenzione
Obesità, Nutrizione e Stili di vit. Trento 31 Mrzo 27 obesità nel bmbino: epidemiologi e prevenzione Cludio Mffeis Diprtimento Mterno Infntile e Biologi-Genetic Sezione di Peditri - Università di Veron
More informationInfluence of the Duration of Diabetes on the Outcome of a Diabetes Self-Management Education Program
Originl Article Clinicl Cre/Eduction http://dx.doi.org/10.4093/dmj.2012.36.3.222 pissn 2233-6079 eissn 2233-6087 D I A B E T E S & M E T A B O L I S M J O U R N A L Influence of the Durtion of Dibetes
More informationOlanzapine for the prophylaxis and rescue of chemotherapyinduced nausea and vomiting (CINV): a retrospective study
Originl Article Olnzpine for the prophylxis nd rescue of chemotherpyinduced nuse nd vomiting (CINV): retrospective study Leonrd Chiu, Nichols Chiu, Ronld Chow, Liying Zhng, Mrk Psetk, Jordn Stinson, Brenne
More informationFeeding state and age dependent changes in melaninconcentrating hormone expression in the hypothalamus of broiler chickens
Supplementry Mterils Epub: No 2017_23 Vol. 65, 2018 https://doi.org/10.183/bp.2017_23 Regulr pper Feeding stte nd ge dependent chnges in melninconcentrting hormone expression in the hypothlmus of broiler
More informationEmerging Options for Thromboprophylaxis After Orthopedic Surgery: A Review of Clinical Data
Emerging Options for Thromboprophylxis After Orthopedic Surgery: A Review of Clinicl Dt Bob L. Lobo, Phrm.D. In four rndomized, controlled studies of ptients undergoing orthopedic surgery, the ntithrombotic
More informationEFFECTS OF AN ACUTE ENTERIC DISEASE CHALLENGE ON IGF-1 AND IGFBP-3 GENE EXPRESSION IN PORCINE SKELETAL MUSCLE
Swine Dy 22 Contents EFFECTS OF AN ACUTE ENTERIC DISEASE CHALLENGE ON IGF-1 AND IGFBP-3 GENE EXPRESSION IN PORCINE SKELETAL MUSCLE B. J. Johnson, J. P. Kyser, J. D. Dunn, A. T. Wyln, S. S. Dritz 1, J.
More informationBody mass index, waist-to-hip ratio, and metabolic syndrome as predictors of middle-aged men's health
Originl Article - Sexul Dysfunction/Infertility pissn 2005-6737 eissn 2005-6745 Body mss index, wist-to-hip rtio, nd metbolic syndrome s predictors of middle-ged men's helth Jung Hyun Prk *, In-Chng Cho
More informationResults. Table 1: Demographic and Baseline Characteristics, Open-Label Safety Population Prior Double-Blind OC/APAP ER (n=77)
Open-Lbel Extension of Rndomized, Double-Blind, Plcebo-Controlled, Phse 3 Study of the Sfety nd Anlgesic Efficcy of MNK-795 Oxycodone/Acetminophen Extended-Relese (OC/APAP ER) Tblets in n Acute Pin Model
More informationHealth Coaching: A Preliminary Report on the Effects in Traumatic Brain Injury/Polytrauma Patients
ORIGINAL RESEARCH Helth Coching: A Preliminry Report on the Effects in Trumtic Brin Injury/Polytrum Ptients Esmerld Mdrigl, MSW; Mx Gry, BA; Molly A. Timmermn, DO; Ttin Orozco, PhD; Dine Cowper Ripley,
More informationEffects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus
Originl Article Others Dibetes Metb J 215;39:335-341 http://dx.doi.org/1.493/dmj.215.39.4.335 pissn 2233-679 eissn 2233-687 DIABETES & METABOLISM JOURNAL Effects of 6-Month Sitgliptin Tretment on Insulin
More informationCommunity. Profile Carter County. Public Health and Safety Division
Community Helth Profile 2015 Crter County Public Helth nd Sfety Division Tble of Contents Demogrphic Informtion 1 Communicble Disese 3 Chronic Disese 4 Mternl nd Child Helth 10 Mortlity 12 Behviorl Risk
More informationSee 17 for PATIENT COUNSELING INFORMATION and FDAapproved patient labeling. Revised: 6/2016 FULL PRESCRIBING INFORMATION: CONTENTS*
1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include ll the informtion needed to use BASAGLAR sfely nd effectively. See full prescribing informtion for BASAGLAR BASAGLAR (insulin glrgine
More informationSoybean Hulls as an Alternative Feed for Horses
Animl Industry Report AS 650 ASL R1931 2004 Soyben Hulls s n Alterntive Feed for Horses Josie Booth Iow Stte University Howrd Tyler Iow Stte University Peggy Miller-Auwerd Iow Stte University Jenette Moore
More informationSupplementary Online Content
Supplementry Online Content Rieckmnn N, Kronish IM, Shpiro PA, Whng W, Dvidson KW. Serotonin reuptke inhibitor use, depression, nd long-term outcomes fter n cute coronry : prospective cohort study. JAMA
More informationEpilepsy & Behavior 20 (2011) Contents lists available at ScienceDirect. Epilepsy & Behavior. journal homepage:
Epilepsy & Behvior 20 (2011) 52 56 Contents lists vilble t ScienceDirect Epilepsy & Behvior journl homepge: www.elsevier.com/locte/yebeh Detecting helth disprities mong Cucsins nd Africn-Americns with
More informationENERGY CONTENT OF BARLEY
ENERGY CONTENT OF BARLEY VARIATION IN THE DIETARY ENERGY CONTENT OF BARLEY Shwn Firbirn, John Ptience, Hnk Clssen nd Ruurd Zijlstr SUMMARY Formultion of commercil pig diets requires n incresing degree
More informationCME Improving Outcomes in Ptients With Primry Generlized Tonic-Clonic Seizures Through Evidence-Bsed Tretments nd Personlized Approches Course Director Steve Chung, MD Messge From the Course Director Full
More informationEffect of kazunoko lipid on the concentrations of plasma glucose and lipids and liver lipids in mice
Effect of kzunoko lipid on the concentrtions of plsm glucose nd lipids nd liver lipids in mice Ntionl Food Reserch Institute Tomoyuki Higuchi, Nouy Shiri nd Hirmitsu Suzuki INTRODUCTION Kzunoko, which
More informationBright Futures Medical Screening Reference Table 2 to 5 Day (First Week) Visit
Bright Futures Medicl Reference Tle 2 to 5 Dy (First Week) Visit Universl Action Metolic nd Verify documenttion of neworn metolic screening results, pproprite rescreening, nd needed follow-up. Document
More informationUsing Paclobutrazol to Suppress Inflorescence Height of Potted Phalaenopsis Orchids
Using Pcloutrzol to Suppress Inflorescence Height of Potted Phlenopsis Orchids A REPORT SUBMITTED TO FINE AMERICAS Linsey Newton nd Erik Runkle Deprtment of Horticulture Spring 28 Using Pcloutrzol to Suppress
More informationShamsuddin M. Mamun, U. Focken, G. Francis and K. Becker University of Hohenheim, Stuttgart, Germany. September 2004
A GROWTH PERFORMANCE AND METABOLIC RATES OF GENETICALLY IMPROVED AND CONVENTIONAL STRAINS OF NILE TILAPIA, OREOCHROMIS NILOTICUS (L.) Shmsuddin M. Mmun, U. Focken, G. Frncis nd K. Becker University of
More informationA Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation
ORIGINAL CONTRIBUTIONS 3 see relted editoril on pge x A Rndomized Phse III Clinicl Tril of Plecntide, Urogunylin Anlog, in Ptients With Chronic Idiopthic Constiption Philip B. Miner Jr, MD, Willim D. Koltun,
More informationA Comparison of Serum Magnesium Level in Pregnant Women with and without Gestational Diabetes Mellitus (GDM)
Brief Report J Bbol Univ Med Sci Vol 18, Issu 12; Dec 2016. P:71-75 A Comprison of Serum Mgnesium Level in Pregnnt Women with nd without Gesttionl Dibetes Mellitus (GDM) Z. Bouzri (MD) 1, F. Elmi(MD) 2,
More informationIMpower133: Primary PFS, OS, and safety in a Ph1/3 study of 1L atezolizumab + carboplatin + etoposide in extensive-stage SCLC
IMpower133: Primry PFS, OS, nd sfety in Ph1/3 study of 1L tezolizumb + crbopltin + etoposide in extensive-stge SCLC S. V. Liu, 1 A. S. Mnsfield, 2 A. Szczesn, 3 L. Hvel, 4 M. Krzkowski, 5 M. J. Hochmir,
More informationInvasive Pneumococcal Disease Quarterly Report. July September 2017
Invsive Pneumococcl Disese Qurterly Report July September 2017 Prepred s prt of Ministry of Helth contrct for scientific services by Rebekh Roos Helen Heffernn October 2017 Acknowledgements This report
More informationY. Yazici 1, D. Moniz Reed 2, C. Klem 2, L. Rosenblatt 2, G. Wu 2, J.M. Kremer 3
Greter remission rtes in ptients with erly versus long-stnding disese in biologic-nive rheumtoid rthritis ptients treted with btcept: post hoc nlysis of rndomised clinicl tril dt Y. Yzici 1, D. Moniz Reed
More informationTHE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS
THE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS THE EVALUATION OF DEHULLED CANOLA MEAL IN THE DIETS OF GROWING AND FINISHING PIGS John F. Ptience nd Doug Gillis SUMMARY
More informationSummary of Package Insert 1
Summry of Pckge Insert 1 For Sttes with Non-Published Policies Indictions Non-infected prtil nd full-thickness skin ulcers due to VSU 2 of greter thn 1 month durtion nd which hve not dequtely responded
More information10-15 mg/day 15 mg/day 30 mg/day. 2-5 mg/day 5-10 mg/day 15 mg/day. 2 mg/day 5-10 mg/day 15 mg/day. 30 mg/day injected IM
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include ll the informtion needed to use ABILIFY sfely nd effectively. See full prescribing informtion for ABILIFY. Tblets ABILIFY DISCMELT
More informationof comorbid conditions, interventions Diagnosis and treatment, treatment reduction of risk factors for CVD to slow disease progression,
Tble 5.1. NKF Clssifiction of Chronic Kidney Disese nd Clinicl Fetures Stge Description GFR (ml/ min/1.73 m 2 ) U.S. Prevlence, b # Affected (%) Clinicl Fetures Action Pln c At incresed risk for CKD >60
More informationOriginal Paper. Med Princ Pract 2017;26: DOI: /
Originl Pper Med Princ Prct 2017;26:146 151 Received: Mrch 28, 2016 Accepted: December 6, 2016 Published online: December 6, 2016 The Assocition of Vitmin D Sttus nd Vitmin D Replcement Therpy with Glycemic
More informationDietary Characteristics of Hong Kong Young Children: Implications for Nutrition Education
HK J Peditr (new series) 2006;11:255-262 Dietry Chrcteristics of Hong Kong Young Children: Implictions for Nutrition Eduction LL HUI, EAS NELSON Abstrct Key words Objectives: To exmine the dietry pttern
More informationSponsor / Company: Sanofi Drug substance(s): AVE0005 (aflibercept)
These results re supplied for informtionl purposes only. Prescribing decisions should be mde bsed on the pproved pckge insert in the country of prescription. Sponsor / Compny: Snofi Drug substnce(s): AVE0005
More informationINVEGA SUSTENNA (paliperidone palmitate) extended-release injectable
(pliperidone plmitte) extended-relese injectble suspension, for intrmusculr use HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include ll the informtion needed to use sfely nd effectively.
More informationPNEUMOVAX 23 is recommended by the CDC for all your appropriate adult patients at increased risk for pneumococcal disease 1,2 :
PNEUMOVAX 23 is recommended y the CDC for ll your pproprite dult ptients t incresed risk for pneumococcl disese 1,2 : Adults ged
More informationContemporary Clinical Trials
Contemporry Clinicl Trils 33 (2012) 881 888 Contents lists vilble t SciVerse ScienceDirect Contemporry Clinicl Trils journl homepge: www.elsevier.com/locte/conclintril A Mediterrnen dietry intervention
More informationDoes increasing physical activity reduce the excess risk of work disability among overweight individuals? 1
1 Does incresing physicl ctivity reduce the excess risk of work disbility mong overweight individuls? 1 by Jenni Ervsti, PhD, 2 Jkko Airksinen, PhD, Jn Pentti, MSc, Jussi Vhter, MD, PhD, Skri Suominen,
More informationSleep Disordered Breathing and Gestational Hypertension: Postpartum Follow-up Study
SDB AND GESTATIONAL HYPERTENSION: POSTPARTUM FOLLOW-UP Sleep Disordered Brething nd Gesttionl Hypertension: Postprtum Follow-up Study John Reid, MD 1 ; Riley A. Glew, MPH 1 ; Robert Skomro, MD 1 ; Mrk
More informationManagement and Outcomes of Binge-Eating Disorder in Adults: Current State of the Evidence
Clinicin Summry Mentl Helth Eting Disorders Mngement nd Outcomes of Binge-Eting Disorder in Adults: Current Stte of the Evidence Focus of This Summry This is summry of systemtic review evluting the evidence
More informationTrends in antihypertensive and lipidlowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?
ORIGINAL ARTICLE Trends in ntihypertensive nd lipidlowering therpy in subjects with type II dibetes: clinicl effectiveness or clinicl discretion? MC Gulliford, J Chrlton nd R Ltinovic Deprtment of Public
More informationEffect of vitamin D on the recurrence rate of rheumatoid arthritis
1812 Effect of vitmin D on the recurrence rte of rheumtoid rthritis JUNXIA YANG 1, LIN LIU 1, QINGLIN ZHANG 2, MEIRONG LI 1 nd JINGYA WANG 1 1 Deprtment of Rheumtology, 2 Centrl Lbortory, Xuzhou Centrl
More informationThe Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. doi: /ajg.2012.
A 12-Week, Rndomized, Controlled Tril with 4-Week Rndomized Withdrwl Period to Evlute the Efficcy nd Sfety of Linclotide in Irritble Bowel Syndrome with Constiption The Hrvrd community hs mde this rticle
More informationSonia Kapur, Ph.D., Margaret N. Groves, M.Phil., David T. Zava, Ph.D., and Sanjay Kapur, Ph.D.
Journl of Dibetes Science nd Technology Volume 4, Issue 2, Mrch 2010 Dibetes Technology Society SYMPOSIUM Postprndil Insulin nd Triglycerides fter Different Brekfst Mel Chllenges: Use of Finger Stick Cpillry
More informationBlood Pressure and Heart Rate Effects, Weight Loss and Maintenance During Long-Term Phentermine Pharmacotherapy for Obesity
nture publishing group rticles Blood Pressure nd Hert Rte Effects, Weight Loss nd Mintennce During Long-Term Phentermine Phrmcotherpy for Obesity Ed J. Hendricks 1,2, Frnk L. Greenwy 3, Eric C. Westmn
More informationRelationship between serum irisin, glycemic indices, and renal function in type 2 diabetic patients
J Renl Inj Prev. 2017; 6(2): 88-92. http://journlrip.com Journl of Renl Injury Prevention DOI: 10.15171/jrip.2017.17 Reltionship between serum irisin, glycemic indices, nd renl function in type 2 dibetic
More informationThe Effects of Diet Particle Size on Animal Performance
MF-2050 Feed Mnufcturing Feed Mnufcturing Cerel grins re the primry energy source in swine nd poultry diets. Therefore, not only must producers be concerned bout the composition of the grin, but lso how
More information2.3. with type 1 diabetes <3 years of age. (8.4)
1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include ll the informtion needed to use HUMALOG sfely nd effectively. See full prescribing informtion for HUMALOG. HUMALOG (insulin lispro
More informationOriginal Investigation. management of type 2 diabetes mellitus.
Reserch Originl Investigtion Roux-en-Y Gstric Bypss Surgery or Lifestyle With Intensive Medicl Mngement in Ptients With Type 2 Dibetes Fesibility nd 1-Yer Results of Rndomized Clinicl Tril Florenci Hlperin,
More informationOptimizing Efficacy, Safety, and Adherence in Patients With Focal Seizures Through Individualized Treatment Regimens
CME Optimizing Efficcy, Sfety, nd Adherence in Ptients With Focl Seizures Through Individulized Tretment Regimens Course Director John (Jck) M. Pellock, MD From the Editor Clinicins involved in the cre
More informationRandomized Controlled Trial to Improve Adiposity, Inflammation, and Insulin Resistance in Obese African-American and Latino Youth
nture publishing group rticles Rndomized Controlled Tril to Improve Adiposity, Inflmmtion, nd Insulin Resistnce in Obese -Americn nd Ltino Youth Rebecc E. Hsson 1, Tnj C. Adm 1, Jimie N. Dvis 1, Louise
More informationAnemia in pediatric hemodialysis patients: Results from the 2001 ESRD Clinical Performance Measures Project
Kidney Interntionl, Vol. 64 (2003), pp. 1120 1124 Anemi in peditric hemodilysis ptients: Results from the 2001 ESRD Clinicl Performnce Mesures Project DIANE L. FRANKENFIELD, ALICA M. NEU, BRADLEY A. WARADY,
More informationComparison of three simple methods for the
J. clin. Pth. (1967), 2, 5 Comprison of three simple methods for the ssessment of 'free' thyroid hormone T. M. D. GIMLETTE1 From the Rdio-Isotope Lbortory, St. Thoms's Hospitl, London SYNOPSIS A dilysis
More informationWater Consumption Increases Weight Loss During a Hypocaloric Diet Intervention in Middle-aged and Older Adults
nture publishing group Wter Consumption Increses Weight Loss During Hypocloric Diet Intervention in Middle-ged nd Older Adults Elizbeth A. Dennis 1, An Lur Dengo 1, Dn L. Comber 1, Kyle D. Flck 2, Jyoti
More informationGlobal Intellectual Deficits in Cystinosis
Americn Journl of Medicl Genetics 49:83-87 (1994) Globl Intellectul Deficits in Cystinosis Brbr L.H. Willims, Jerry A. Schneider, nd Doris A. Truner Deprtments of Neurosciences (B.L.H.W.. D.A.T.) nd Peditrics
More informationChilblains (pernio, perniosis) are cold-induced, painful or itching
Nifedipine vs Plcebo for Tretment of Chronic Chilblins: A Rndomized Controlled Tril Ibo H. Souwer, MD 1 Jcobus H. J. Bor, BSc (Mth) 2 Pul Smits, MD, PhD 3 Antoine L. M. Lgro-Jnssen, MD, PhD 1 1 Deprtment
More informationSummary. Effect evaluation of the Rehabilitation of Drug-Addicted Offenders Act (SOV)
Summry Effect evlution of the Rehbilittion of Drug-Addicted Offenders Act (SOV) The Rehbilittion of Drug-Addicted Offenders Act (SOV) ws lunched on April first 2001. This lw permitted the compulsory plcement
More informationWSU Tree Fruit Research and Extension Center, Wenatchee (509) ext. 265;
FINAL REPORT WTFRC Project # AH-1-5 WSU Project # 13C-355-3 Project title: PI: Orgniztion: Coopertors: of Sunburn in Apples with RAYNOX Lrry Schrder, Horticulturist WSU Tree Fruit Reserch nd Extension
More informationRisks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria
Clinicl Prctice: Mini-Review Received: My 20, 2016 Accepted fter revision: December 14, 2016 Published online: Jnury 27, 2017 Risks for All-Cuse Mortlity: Strtified by Age, Estimted Glomerulr Filtrtion
More information